Stay updated on Finerenone in HF with LVEF ≥40% Clinical Trial
Sign up to get notified when there's something new on the Finerenone in HF with LVEF ≥40% Clinical Trial page.

Latest updates to the Finerenone in HF with LVEF ≥40% Clinical Trial page
- Check7 days agoChange DetectedThe Taiwan site entry was updated from Taoyuan District to Taoyuan city, clarifying the location as Taoyuan, Taiwan, 33305 for that study site.SummaryDifference0.0%

- Check14 days agoChange DetectedRevision tag updated from v3.5.2 to v3.5.3, indicating a minor update to the page’s platform. No study content or data is changed by this update.SummaryDifference0.0%

- Check21 days agoChange DetectedUpdates include corrected spelling/formatting for two listed locations and a revised citation entry for a journal article. The page’s displayed site revision version is also updated.SummaryDifference0.0%

- Check37 days agoChange DetectedAdded two 2026 JAMA Cardiol. publications related to the FINEARTS-HF trial: EMPEROR-Preserved Risk Model and Outcomes in the FINEARTS-HF Trial, and Biomarker, Functional Status, and Quality-of-Life Trajectories Before Modes of Death in Heart Failure.SummaryDifference0.0%

- Check44 days agoChange DetectedA new JAMA Cardiol. 2025 publication is added to the Publications section, and the Erratum for that article is removed.SummaryDifference0.0%

- Check51 days agoChange DetectedThe Napoli entry is updated to Naples, Campania, Italy (80131), and a Nat Med 2024 publication on FINE-HEART with the full author list is added; the study record revision is updated to v3.5.0.SummaryDifference0.0%

Stay in the know with updates to Finerenone in HF with LVEF ≥40% Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Finerenone in HF with LVEF ≥40% Clinical Trial page.